Integrative oncology: complementary therapies, herbs, and other OTC agents. Mediterranean diet.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2009 AND VI 23 AND IP 14
Results: 38
1
2
Second opinion. Recurrent urothelial carcinoma with pulmonary metastasis.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
CME post-test.
- Published in:
- 2009
- Publication type:
- Journal Article
4
Survivin(g) adult T-cell leukemia/lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
Hepatocellular carcinoma: the search for innovative adjuvant therapies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
6
Adjuvant treatment after orthotopic liver transplantation: is it really necessary?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
7
Adult T-cell leukemia/lymphoma: complexities in diagnosis and novel treatment strategies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
8
Current management of adult T-cell leukemia/lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
9
Survivin(g) Adult T-cell Leukemia/Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1256
- By:
- Publication type:
- Article
10
Getting a handle on posttransplant recurrence of HCC.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
11
CYP2D6 testing in breast cancer: ready for prime time?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
12
CYP2D6 testing for breast cancer patients: is there more to the story?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
13
Tamoxifen, endoxifen, and CYP2D6: the rules for evaluating a predictive factor.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
14
Advances in Optimizing Therapy and Quality of Life for People With Hard-to-Treat Blood Cancers.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1296
- Publication type:
- Article
15
NCCN guidelines for NHL, kidney cancer updated with new drugs.
- Published in:
- 2009
- Publication type:
- Journal Article
16
Voreloxin gets orphan drug status for acute myeloid leukemia.
- Published in:
- 2009
- Publication type:
- Journal Article
17
Innovative Strategies Improve Outcomes and Reduce Complications Associated With Stem Cell Transplants.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1308
- Publication type:
- Article
18
Perifosine fast-tracked for the treatment of relapsed/refractory multiple myeloma.
- Published in:
- 2009
- Publication type:
- Journal Article
19
Getting a Handle on Posttransplant Recurrence of HCC.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1287
- By:
- Publication type:
- Article
20
FDA grants orphan drug designation for TNFerade.
- Published in:
- 2009
- Publication type:
- Journal Article
21
Mediterranean Diet.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1315
- By:
- Publication type:
- Article
22
CMS releases 2010 physician fee schedule.
- Published in:
- 2009
- Publication type:
- Journal Article
23
Adjuvant Treatment After Orthotopic Liver Transplantation: Is It Really Necessary?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1276
- By:
- Publication type:
- Article
24
Advances in Genetics and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders.
- Published in:
- 2009
- Publication type:
- Abstract
25
Recurrent Urothelial Carcinoma With Pulmonary Metastasis.
- Published in:
- 2009
- By:
- Publication type:
- Proceeding
26
Adult T-cell Leukemia/Lymphoma: Complexities in Diagnosis and Novel Treatment Strategies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1267
- By:
- Publication type:
- Article
27
Hepatocellular Carcinoma: The Search for Innovative Adjuvant Therapies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1291
- By:
- Publication type:
- Article
28
Current Management of Adult T-Cell Leukemia/Lymphoma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1250
- By:
- Publication type:
- Article
29
CYP2D6 Testing for Breast Cancer Patients: Is There More to the Story?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1236
- By:
- Publication type:
- Article
30
Tamoxifen, Endoxifen, and CYP2D6: The Rules for Evaluating a Predictive Factor.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1233
- By:
- Publication type:
- Article
31
CYP2D6 Testing in Breast Cancer: Ready for Prime Time?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1223
- By:
- Publication type:
- Article
32
NCCN Guidelines for NHL, Kidney Cancer Updated With New Drugs.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1221
- Publication type:
- Article
33
Perifosine Fast-Tracked for the Treatment of Relapsed/Refractory Multiple Myeloma.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1221
- Publication type:
- Article
34
Voreloxin Gets Orphan Drug Status for Acute Myeloid Leukemia.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1221
- Publication type:
- Article
35
FDA Grant's Orphan Drug Designation for TNFerade.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1221
- Publication type:
- Article
36
ASCO Issues Annual Progress Report on Top Cancer Research Advances.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1217
- Publication type:
- Article
37
CMS Releases 2010 Physician Fee Schedule.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1214
- Publication type:
- Article
38
Major Cancer Agencies Respond to USPSTF's New Mammography Guidelines.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1199
- Publication type:
- Article